Physician profile
Emma D Denis
NPI 1851512503
$3,698.05
in general payments reported to CMS, 2019-2025
31 companies · $1,158 in 2025
The $1,158 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $247 · 2021: $405 · 2022: $545 · 2023: $488 · 2024: $599 · 2025: $1,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909 · Education: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,908.85 |
| Education | $336.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,329.57 | 2019-2025 | Puraply, Via Matrix, Novachor |
| Djo, LLC | $395.67 | 2019-2025 | Dr Comfort |
| Paratek Pharmaceuticals, INC. | $286.89 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $275.60 | 2020-2025 | Stravix, Grafix Pl |
| Abbvie INC. | $230.13 | 2021-2022 | |
| Sanara Medtech INC. | $168.38 | 2021-2022 | |
| Horizon Therapeutics Plc | $141.37 | 2019-2021 | |
| Melinta Therapeutics, LLC | $88.02 | 2019-2021 | |
| Access Pro Medical, LLC | $70.43 | 2023 | Matriderm |
| Averitas Pharma INC. | $68.41 | 2025 | Qutenza |
| Bioventus LLC | $57.89 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Reprise Biomedical, INC. | $51.04 | 2024-2025 | Miro3d |
| Biowound Solutions, INC. | $47.66 | 2025 | Bio-Connekt |
| Medtronic, INC. | $46.01 | 2022 | |
| Merck Sharp & Dohme LLC | $44.45 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $42.82 | 2020 | |
| Alfasigma USA, INC. | $39.17 | 2020 | |
| Integra Lifesciences Corporation | $38.64 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $34.30 | 2025 | |
| Biotissue Holdings INC. | $25.50 | 2021 | |
| Nabriva Therapeutics, Plc | $25.29 | 2022 | |
| Kerecis Limited | $24.14 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Wright Medical Technology, INC. | $23.79 | 2019 | |
| Acera Surgical, INC. | $21.21 | 2025 | Restrata Wound Matrix |
| Assertio Therapeutics, INC. | $20.35 | 2019 | |
| Orthofix Medical, INC. | $19.91 | 2025 | Physio-Stim |
| Acelrx Pharmaceuticals, INC. | $19.53 | 2020 | |
| Treace Medical Concepts, INC. | $17.40 | 2022 | |
| Dynasplint Systems INC. | $17.26 | 2019 | |
| Osiris Therapeutics INC. | $14.18 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.04 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Denis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.